The Food and Drug Administration has removed the black box warning from hormone replacement therapy (HRT) labels after more than two decades, marking a significant shift in how the agency communicates risks associated with menopausal hormone treatments. The decision affects estrogen-alone and estrogen-plus-progestin therapies prescribed to manage menopausal symptoms like hot flashes, night sweats, and vaginal dryness.
The black box warning was initially added in 2003 following results from the Women’s Health Initiative study, which raised concerns about increased risks of cardiovascular disease, stroke, blood clots, and breast cancer in some women using HRT. This warning became the most prominent safety alert on medication labeling, leading many women and their physicians to avoid hormone therapy even when symptoms significantly impacted quality of life.
The FDA’s decision to remove the boxed warning does not mean these risks have disappeared. Instead, the agency determined that the current label format, with detailed risk information presented throughout the prescribing information, more appropriately conveys the nuanced safety profile of these medications. The updated labeling will continue to include comprehensive risk information, but without the prominent black box that previously dominated the packaging.
Medical experts have increasingly recognized that HRT risks vary significantly based on factors including a woman’s age when starting therapy, time since menopause, and individual health history. For many women who begin treatment within 10 years of menopause onset, the benefits of symptom relief may outweigh potential risks when used at the lowest effective dose for the shortest duration needed.
This regulatory change may encourage more informed conversations between women and their healthcare providers about managing menopausal symptoms. Physicians emphasize that HRT decisions should remain individualized, weighing each patient’s symptoms, risk factors, and personal preferences rather than being guided primarily by blanket warnings that may not reflect current scientific understanding.
